Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Sarah L. Kerns"'
Autor:
Adam J. Webb, Emily Harper, Tim Rattay, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Alessandro Cicchetti, Dirk De Ruysscher, Maria Carmen De Santis, Alison M. Dunning, Rebecca M. Elliott, Laura Fachal, Antonio Gómez-Caamaño, Sara Gutiérrez-Enríquez, Kerstie Johnson, Ramón Lobato-Busto, Sarah L. Kerns, Giselle Post, Tiziana Rancati, Victoria Reyes, Barry S. Rosenstein, Petra Seibold, Alejandro Seoane, Paloma Sosa-Fajardo, Elena Sperk, Begoña Taboada-Valladares, Riccardo Valdagni, Ana Vega, Liv Veldeman, Tim Ward, Catharine M. West, R. Paul Symonds, Christopher J. Talbot
Publikováno v:
EBioMedicine, Vol 84, Iss , Pp 104269- (2022)
Summary: Background: Circadian rhythm impacts broad biological processes, including response to cancer treatment. Evidence conflicts on whether treatment time affects risk of radiotherapy side-effects, likely because of differing time analyses and ta
Externí odkaz:
https://doaj.org/article/097e7e00ef4744c287a2116c62e23053
Autor:
Kayla Collado, BA, Sarah L. Kerns, PhD, MPH, Michael A. Diefenbach, PhD, Elizabeth Peterson-Roth, PhD, Raymond Koski, PhD, Harry Ostrer, MD, Richard G. Stock, MD, Martin Mattessich, Paul Kaplan, PhD, Barry S. Rosenstein, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 897-904 (2020)
Purpose: A genetic test predicting susceptibility for the development of toxicities after prostate cancer radiation therapy is in development. This test intends to help physicians with treatment decision making. Methods and Materials: Radiation oncol
Externí odkaz:
https://doaj.org/article/1aa32a1bdf8f4aba8ec9f221e1b8c90d
Autor:
Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, Paolo Zunino, Andrea Manzoni, Nicola Rares Franco, Liv Veldeman, Piet Ost, Valérie Fonteyne, Christopher J. Talbot, Tim Rattay, Adam Webb, Paul R. Symonds, Kerstie Johnson, Maarten Lambrecht, Karin Haustermans, Gert De Meerleer, Dirk de Ruysscher, Ben Vanneste, Evert Van Limbergen, Ananya Choudhury, Rebecca M. Elliott, Elena Sperk, Carsten Herskind, Marlon R. Veldwijk, Barbara Avuzzi, Tommaso Giandini, Riccardo Valdagni, Alessandro Cicchetti, David Azria, Marie-Pierre Farcy Jacquet, Barry S. Rosenstein, Richard G. Stock, Kayla Collado, Ana Vega, Miguel Elías Aguado-Barrera, Patricia Calvo, Alison M. Dunning, Laura Fachal, Sarah L. Kerns, Debbie Payne, Jenny Chang-Claude, Petra Seibold, Catharine M. L. West, Tiziana Rancati
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: REQUITE (validating pREdictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve QUalITy of lifE in cancer survivors) is an international prospective cohort study. The purpose of this project was to analyse
Externí odkaz:
https://doaj.org/article/78aa783fab71469e852e36d868f430d7
Autor:
Sarah L. Kerns, Leila Dorling, Laura Fachal, Søren Bentzen, Paul D.P. Pharoah, Daniel R. Barnes, Antonio Gómez-Caamaño, Ana M. Carballo, David P. Dearnaley, Paula Peleteiro, Sarah L. Gulliford, Emma Hall, Kyriaki Michailidou, Ángel Carracedo, Michael Sia, Richard Stock, Nelson N. Stone, Matthew R. Sydes, Jonathan P. Tyrer, Shahana Ahmed, Matthew Parliament, Harry Ostrer, Barry S. Rosenstein, Ana Vega, Neil G. Burnet, Alison M. Dunning, Gillian C. Barnett, Catharine M.L. West
Publikováno v:
EBioMedicine, Vol 10, Iss C, Pp 150-163 (2016)
Nearly 50% of cancer patients undergo radiotherapy. Late radiotherapy toxicity affects quality-of-life in long-term cancer survivors and risk of side-effects in a minority limits doses prescribed to the majority of patients. Development of a test pre
Externí odkaz:
https://doaj.org/article/6a03d9a7bdc9422d837243b1ccbd49a0
Autor:
John Kang, Tiziana Rancati, Sangkyu Lee, Jung Hun Oh, Sarah L. Kerns, Jacob G. Scott, Russell Schwartz, Seyoung Kim, Barry S. Rosenstein
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is p
Externí odkaz:
https://doaj.org/article/d7558b7a656845fb86030dc8408fbfc3
Autor:
David Azria, Ariane Lapierre, Sophie Gourgou, Dirk De Ruysscher, Jacques Colinge, Philippe Lambin, Muriel Brengues, Tim Ward, Søren M. Bentzen, Hubert Thierens, Tiziana Rancati, Christopher J. Talbot, Ana Vega, Sarah L. Kerns, Christian Nicolaj Andreassen, Jenny Chang-Claude, Catharine M. L. West, Corey M. Gill, Barry S. Rosenstein
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
The ability to stratify patients using a set of biomarkers, which predict that toxicity risk would allow for radiotherapy (RT) modulation and serve as a valuable tool for precision medicine and personalized RT. For patients presenting with tumors wit
Externí odkaz:
https://doaj.org/article/fac54116a292418e962d9e8764526a1b
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
There is sometimes concern over the use of radiotherapy for cancer in individuals with rheumatoid arthritis (RA), but there is little evidence to support its avoidance. Identifying any association between RA and risk of radiotherapy toxicity could im
Externí odkaz:
https://doaj.org/article/38f2b402d1f24ff6b9b3c50116be35f9
Publikováno v:
International Journal of Radiation Biology. :1-9
Autor:
Lotte van der Weijst, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, Rebecca M. Elliott, Dawn Ennis, Corinne Faivre-Finn, Marzia Franceschini, Tommaso Giandini, Alexandra Giraldo, Sara Gutiérrez-Enríquez, Carsten Herskind, Daniel S. Higginson, Sarah L. Kerns, Kerstie Johnson, Maarten Lambrecht, Philippe Lang, Mónica Ramos, Tiziana Rancati, Andreas Rimner, Barry S. Rosenstein, Dirk De Ruysscher, Ahmed Salem, Claudia Sangalli, Petra Seibold, Paloma Sosa Fajardo, Elena Sperk, Hilary Stobart, Holly Summersgill, Veerle Surmont, Paul Symonds, Begoña Taboada-Valladares, Christopher J. Talbot, Ana Vega, Liv Veldeman, Marlon R. Veldwijk, Tim Ward, Adam Webb, Catharine M.L. West, Yolande Lievens
Publikováno v:
Radiotherapy and Oncology, 176, 127-137. Elsevier Ireland Ltd
BACKGROUND AND PURPOSE: To investigate the association between clinician-scored toxicities and patient-reported health-related quality of life (HRQoL), in early-stage (ES-) and locally-advanced (LA-) non-small cell lung cancer (NSCLC) patients receiv
Publikováno v:
JU Open Plus. 1